
Join to View Full Profile
1301 Central DrSanford, NC 27330
Phone+1 919-718-9512
Fax+1 919-718-9516
Dr. Chang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Emily Chang is a nephrologist based in Sanford, NC, with a residency in Internal Medicine and a fellowship in Nephrology from University of North Carolina Hospitals. She graduated from the University of North Carolina at Chapel Hill School of Medicine in 2007. Her expertise includes general nephrology, cystic kidney disease, and palliative care medicine. Dr. Chang has published several research articles in notable journals such as BMC Nephrology and Kidney Medicine, with her work on volume assessment being cited by other publications. She has been involved in clinical trials focusing on contrast-enhanced ultrasound as a tool for kidney cancer assessment. Dr. Chang has also received multiple CMS Meaningful Use Stage certifications from Epic Systems Corporation and UNC Health Care.
Education & Training
University of North Carolina HospitalsFellowship, Nephrology, 2010 - 2013
University of North Carolina HospitalsResidency, Internal Medicine, 2007 - 2010
University of North Carolina at Chapel Hill School of MedicineClass of 2007
Certifications & Licensure
NC State Medical License 2007 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification WebCIS, UNC Health Care, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Contrast-enhanced Ultrasound of the Kidney Start of enrollment: 2016 Feb 01
- Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau Start of enrollment: 2019 Sep 23
- Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging Start of enrollment: 2020 Oct 07
Publications & Presentations
PubMed
- Feasibility of contrast-enhanced ultrasound as a screening tool for patients at high risk for kidney malignancies.Arian Azarang, Virginie Papadopoulou, Kennita A Johnson, Rachel W Walmer, Kristen Olinger
Translational Andrology and Urology. 2026-06-30 - Noninvasive assessment of volume status in patients with end-stage kidney disease using a wearable monitor and cutaneous hydration sensor.Melissa C Caughey, Dhatri Kakarla, Sora Lee, Simran K Singh, Caroline J Poulton
BMC Nephrology. 2025-07-10 - In Reply to "Pulse of Prudence: Navigating Isolated Lung Ultrasound in Hemodialysis Patients".Emily H Chang, Jennifer E Flythe
Kidney Medicine. 2024-08-01
Press Mentions
AKI Intervention Through Personalized Recommendations Falls Short of Improving Patient OutcomesOctober 26th, 2024
Limited Kidney Benefits with Finerenone in Heart FailureOctober 26th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









